Cammarata, Edoardo, et al. “Impact of Disease Activity-Guided Dose Reduction on IL-17 and IL-23 Inhibitors in Psoriasis: A Real-World Assessment of Efficacy, Safety, and Economic Benefits”. Dermatology Practical & Conceptual, vol. 15, no. 3, July 2025, p. 5845, https://doi.org/10.5826/dpc.1503a5845.